224 filings
Page 6 of 12
424B3
aq0m6hzp2mkv
3 May 22
Prospectus supplement
4:16pm
8-K
2uhaqy590af30
3 May 22
Other Events
4:11pm
424B3
rdc9oq2 ve3z
3 May 22
Prospectus supplement
4:06pm
EFFECT
mtarbo 5y6mgy7d9
8 Apr 22
Notice of effectiveness
12:15am
POS AM
eg6nz0w a54pdss5d011
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
8-K
pycyctsi fudsq63f
31 Mar 22
Celularity Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:06pm
424B3
542o79eqdywwga
16 Mar 22
Prospectus supplement
4:11pm
8-K
4ofe 9x6t
16 Mar 22
Other Events
4:06pm
424B3
jeow0 lcuuj2t
1 Mar 22
Prospectus supplement
4:51pm
8-K
w0v 64rcu
1 Mar 22
Entry into a Material Definitive Agreement
4:47pm
424B3
zpaj3j
16 Feb 22
Prospectus supplement
8:36am
8-K
gzny78m4vgj prp
16 Feb 22
Other Events
8:31am
424B3
vimkg1d
18 Jan 22
Prospectus supplement
4:11pm
8-K
9rxymv fo
18 Jan 22
Other Events
4:06pm
424B3
ig8pa7akv72jo
28 Dec 21
Prospectus supplement
4:05pm
8-K
9kc8 6l50quxf
28 Dec 21
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
4:01pm
424B3
9s96n jpnzz
17 Dec 21
Prospectus supplement
8:35am
8-K
ls4i7dyork
17 Dec 21
Other Events
8:30am